Zpac 260mg Injection

Paclitaxel (260mg) Primary uses of : Breast cancer, Non-small cell lung cancer, Pancreatic cancer
Manufacturer: RPG Life Sciences Ltd
*
₹ 10,515.20 incl tax
Expert advice for Zpac Injection Inform your doctor if you have a history of heart problems, liver problems or low production of blood cells from the bone marrow (myelosupression). Seek immediate medical attention if you observe allergic reactions such as shortness of breath, irregular heart-beats, dizziness, swelling of face or rash; tingling, burning or numbness in finger or toes. Inform your doctor if you are taking radiation therapy of the lungs or if you have Kaposi’s sarcoma with a sore or inflamed mouth. Women on this therapy should use two methods of contraception and 3 months after it. Men who are going to use this therapy should not father a child and 3 months post it. They should also seek guidance and counselling on sperm conservation before taking this therapy. Do not drive or operate machinery as paclitaxel may cause some dizziness, nausea or tiredness. Paclitaxel is not recommended for children below 18 years. Ensure that you receive anti-allergic medication before the therapy to prevent any allergic response.
Composition Paclitaxel (260mg)
Potentially Unsafe With Lactation
Side Effect Common Nausea, Vomiting, Weakness, Rash, Low blood platelets, Upper respiratory tract infection, Urinary tract infection, Bleeding, Anemia (low number of red blood cells), Decreased blood pressure, Flushing (sense of warmth in the face, ears, neck and trunk), Peripheral neuropathy (tingling and numbness of feet and hand), Hair loss, Diarrhoea, Decreased white blood cell count (neutrophils).
How to works How Zpac Injection works Zpac 260mg Injection blocks replication of genetic material (DNA) in the cancer cells. Thus it stops the growth and multiplication of cancer cells.